| Year | Title | Author(s) |
| 2024 |
Multiplex immunohistochemistry elucidates increased distance between cytotoxic T cells and plasma cells in relapsed myeloma, and identifies Lag-3 as the most common checkpoint receptor on cytotoxic T cells of myeloma patients
Haematologica |
Ninkovic, S Purton, LE Harrison, SJ Quach, H |
| 2024 |
Targeting the ribosome to treat multiple myeloma
Molecular Therapy Oncology |
Maclachlan, KH Gitareja, K Kang, J Cuddihy, A Cao, YX Hein, N Cullinane, C Ang, CS Brajanovski, N Pearson, RB Khot, A Sanij, E Hannan, RD Poortinga, G Harrison, SJ |
| 2019 |
Cell surface glucose-regulated protein 78 (GRP78) is upregulated in plasma cells of patients with multiple myeloma compared to monoclonal gammopathy of uncertain significance
Clinical Lymphoma Myeloma & Leukemia |
Ninkovic, S Straszkowski, L Dey, A Tam, C Nandurkar, H Harrison, SJ Purton, L Quach, H |
| 2016 |
T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments
Nature |
Hawkins, ED Duarte, D Akinduro, O Khorshed, RA Passaro, D Nowicka, M Straszkowski, L Scott, MK Rothery, S Ruivo, N Foster, K Waibel, M Johnstone, RW Harrison, SJ Westerman, DA Quach, H Gribben, J Robinson, MD Purton, LE Bonnet, D Lo Celso, C |
| 2015 |
Myelosuppressive Therapies Significantly Increase ProInflammatory Cytokines and Directly Cause Bone Loss
Journal Of Bone And Mineral Research |
Quach, JM Askmyr, M Jovic, T Baker, EK Walsh, NC Harrison, SJ Neeson, P Ritchie, D Ebeling, PR Purton, LE |